We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-9.67%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$2.05B
AUM Growth
+$174M
Cap. Flow
+$354M
Cap. Flow %
17.24%
Top 10 Hldgs %
26.45%
Holding
190
New
45
Increased
56
Reduced
57
Closed
32

Top Buys

Rank Stock Value
1
SOLV icon
Solventum
SOLV
+$50M
2
GPN icon
Global Payments
GPN
+$29.6M
3
APTV icon
Aptiv
APTV
+$29.1M
4
COUR icon
Coursera
COUR
+$23.9M
5
NEM icon
Newmont
NEM
+$23.2M

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$38.8M
2
ADM icon
Archer Daniels Midland
ADM
+$37.9M
3
CAG icon
Conagra Brands
CAG
+$25.2M
4
WEX icon
WEX
WEX
+$23M
5
SMAR
Smartsheet Inc.
SMAR
+$21.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.97%
2 Technology 15.71%
3 Healthcare 12.23%
4 Communication Services 9.72%
5 Energy 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMP icon
76
Compass Minerals
CMP
$1.15B
$8.08M 0.39%
782,368
+306,764
+64% +$3.96M
CART icon
77
Maplebear
CART
$11.8B
$7.97M 0.39%
247,862
+127,619
+106% +$4.39M
EPD icon
78
Enterprise Products Partners
EPD
$81.7B
$7.95M 0.39%
274,474
-10,883
-4% -$312K
SHEL icon
79
Shell
SHEL
$245B
$7.52M 0.37%
104,131
-128,184
-55% -$9.16M
EVTC icon
80
Evertec
EVTC
$1.78B
$7.38M 0.36%
221,932
+161,618
+268% +$5.84M
MMM icon
81
3M
MMM
$94.3B
$7.32M 0.36%
71,590
-397,987
-85% -$38.8M
OMCL icon
82
Omnicell
OMCL
$1.68B
$7.27M 0.35%
268,695
+85,580
+47% +$2.48M
GEO icon
83
The GEO Group
GEO
$4.04B
$7.19M 0.35%
500,998
-18,814
-4% -$266K
DOCU
84
DocuSign
DOCU
$11.5B
$7.17M 0.35%
+133,953
New +$7.55M
MD icon
85
Pediatrix Medical
MD
$2.2B
$7.04M 0.34%
932,108
-40,741
-4% -$337K
G icon
86
Genpact
G
$5.76B
$7.01M 0.34%
+217,842
New +$7.03M
VRN
87
DELISTED
Veren
VRN
$6.9M 0.34%
876,731
-1,219,195
-58% -$10.3M
AVD icon
88
American Vanguard Corp
AVD
$68.9M
$6.67M 0.32%
775,904
-16,277
-2% -$166K
ZD icon
89
Ziff Davis
ZD
$1.98B
$6.65M 0.32%
120,709
+23,571
+24% +$1.3M
TRIP icon
90
TripAdvisor
TRIP
$1.26B
$6.6M 0.32%
370,742
-135,742
-27% -$2.94M
CNXC icon
91
Concentrix
CNXC
$1.57B
$6.58M 0.32%
+103,948
New +$6.24M
INCY icon
92
Incyte
INCY
$24.4B
$6.44M 0.31%
+106,237
New +$6.02M
RGP icon
93
Resources Connection
RGP
$145M
$6.34M 0.31%
573,836
+280,888
+96% +$3.16M
PLOW icon
94
Douglas Dynamics
PLOW
$1.02B
$5.95M 0.29%
254,470
+128,787
+102% +$3.06M
RSKD icon
95
Riskified
RSKD
$716M
$5.75M 0.28%
899,319
+136,116
+18% +$770K
TDOC icon
96
Teladoc Health
TDOC
$1.3B
$5.65M 0.28%
577,785
+391,067
+209% +$4.77M
FLYW icon
97
Flywire
FLYW
$2.16B
$5.56M 0.27%
+339,257
New +$6.4M
WRBY icon
98
Warby Parker
WRBY
$3.27B
$5.5M 0.27%
342,767
-74,489
-18% -$1.1M
MG icon
99
Mistras Group
MG
$512M
$5.49M 0.27%
662,266
-120,391
-15% -$1.05M
SWN
100
DELISTED
Southwestern Energy Company
SWN
$5.45M 0.27%
809,668
-1,647,399
-67% -$12M
2 3
4
5 6

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return

Invenomic Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Invenomic Capital Management held 190 positions worth $2.05B, up 9.3% from $1.88B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Invenomic Capital Management deployed $354M of net new capital in Q2 2024, opening 45 new positions and adding to 56 existing holdings. Its largest new stake was Solventum: 824,185 shares worth $43.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was 3M, an estimated $38.8M trimmed.

  • Invenomic Capital Management's largest Q2 2024 buy was Solventum: 824,185 shares worth $43.6M.
  • Invenomic Capital Management added most to Global Payments in Q2 2024, an estimated $29.6M increase.
  • Invenomic Capital Management's biggest Q2 2024 reduction was 3M, cutting an estimated $38.8M.
  • Invenomic Capital Management fully exited Archer Daniels Midland in Q2 2024, selling an estimated $37.9M.
  • Invenomic Capital Management's ten largest holdings make up 26% of its $2.05B portfolio in Q2 2024.
  • Invenomic Capital Management opened 45 new positions and closed 32 in Q2 2024.
  • Invenomic Capital Management's portfolio value rose 9.3% quarter-over-quarter to $2.05B.

Based on Invenomic Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.